Skip to main content
Premium Trial:

Request an Annual Quote

Stanford Med, Intermountain Healthcare Collaborate on Clinical Genomics

NEW YORK (GenomeWeb) – Stanford Medicine and Intermountain Healthcare have teamed up on clinical genomics research.

The partners announced a new research team comprised of scientists at the Stanford Genome Technology Center (SGTC) and Intermountain's Precision Genomics Core Laboratory who will apply molecular analysis to patient care. As part of the collaboration, they will seek to identify new biomarkers using technology from SGTC.

"The research agreement allows for the joint development of innovative technologies to enable clinical research focused on precision medicine and directly address critical questions in precision health," Intermountain Healthcare's Executive Director of Precision Medicine and Precision Genomics Lincoln Nadauld said in a statement. "Likewise, this will provide Stanford with an invaluable opportunity to conduct clinical population-based studies that will accelerate adoption of precision health."

Intermountain Healthcare and Stanford Medicine have each announced commitments to support President Obama's Precision Medicine Initiative.